In a study released at the annual meeting of the American Society of Clinical Oncology last weekend, experts believe they have made a paradigm shifting discovery in preventing breast cancer, CBS reports.
"We've gotten very good at treating breast cancer. Now, the bent of the research is focused on prevention," Dr. Jennifer Ashton told the news source.
Researchers found that the drug Aromasin reduced the risk of invasive breast cancer by 65 percent in women that were post-menopausal, and therefore at a high risk for the disease and increased life insurance payments, according to the study, published in the New England Journal of Medicine.
Aromasin is currently being used to prevent the recurrence of breast cancer in women in recovery. The drug blocks the production of estrogen in patients, which is believed to promote breast tumors, according to the media outlet.
"In this study and in general," Ashton added, "when you talk about high risk for breast cancer, age is the number one factor. Over the age of 60 were the women in this study. Post menopausal women. Other things that make you high-risk: your family history, or if you've had another type of breast cancer in the past."